Burden of Vaccine-Preventable Diseases in People Living with HIV.

Vaccines (Basel)

The Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Department of Medicine, Emory University, Decatur, GA 30030, USA.

Published: July 2024

Vaccine-preventable diseases (VPDs) pose a serious public health concern for people living with HIV (PLH). PLH experience a delayed and weakened response to many vaccines available, compared to the general population. Lower seroconversion rates, along with a decreased efficacy and durability of vaccines, increases the susceptibility of PLH to VPDs. Vaccination guidelines specifically targeting this population have been modified to overcome these challenges. However, vaccine uptake remains suboptimal due to multiple barriers, highlighting the need for further studies and the additional implementation of public health measures specifically tailored to PLH.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11281599PMC
http://dx.doi.org/10.3390/vaccines12070780DOI Listing

Publication Analysis

Top Keywords

vaccine-preventable diseases
8
people living
8
living hiv
8
public health
8
burden vaccine-preventable
4
diseases people
4
hiv vaccine-preventable
4
diseases vpds
4
vpds pose
4
pose serious
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!